EFTA00619607.pdf

IntelliCell BioSciences Inc. Revenues Quarterly Performance Summary HurDA $14,000,000 $4,500,000 $4,000,000 $12,000,000 $3,500,000 $10,000,000 - $3,000,000 $2,500,000 $8,000,000 - — $2,000,000 $1,500,000 $6,000,000 - $1,000,000 $4,000,000 - $500,000 $ $2,000,000 - $(500,000) 5- $(1,000,000) Mar-11 Jun-11 Sep-11 Dec-11 Mar-12 Jun-12 Sep-12 Dec-12 gesEllITDA $(444,675) $(601,879) $(242,119) $233,061 $606,203 $1,501,986 $2,588,991 $3,891,264 STotal Revenues $183,520 $433,920 $1,685,600 $3,345,380 $4,788,440 $6,791,220 $9,190,300 $11,717,980 Quarterly Performance Chart Confidential IntelliCell Financial Plan US 01-2011 revl.xlsx EFTA00619607  IntelliCell BioSciences Inc. Quarterly Revenue Summary $16,000,000 $14,000,000 $12,000,000 $10,000,000 $8,000,000 V $6,000,000 $4,000,000 $2,000,000 Mar-11 Jun-12 Sep-12 Dec-12 ■ Banking $36,000 $108,000 $232,500 $407,250 $600,000 $826,500 $1,075,500 $1,315,500 ■ Processing Kits-Distributors $183,700 $354,740 $532,220 $758,510 $1,023,450 $1,295,290 ■ Equipment Sales - Distributors $183,520 $433,920 $1,685,600 $6,791,220 $9,190,300 $11,717,980 ■ Licensing Revenues - installations $3,520 $13,920 $95,880 $264,220 $381,300 Quarterly Revenue Chart Confidential IntelliCell Financial Plan US 01-2011 revl.xlsx EFTA00619608  IntelliCell Biosciences Inc. North America Division Three Year Launch Plan Forecast Quarterly Income Statement Forecast Start Date: 1-1an-11 Quarter ended Year ended Quarter ended Year ended Year ended 31-Mar-11 30-1un-11 30-Seo-11 31-Dec-11 31-Dec-11 31-Mar-12 30-1un-12 30-Seo-12 31-Dec-12 31-Dec-12 31-Dec-13 Month 3 Month 6 Month 9 Month 12 Month 12 Month 15 Month 18 Month 21 Month 24 Month 24 Month 36 Revenues Licensing Revenues - Installations $ 60,000 5 60,000 5 100,000 $ 100,000 $ 320,000 $ 60,000 $ 60,000 $ 40,000 $ 40000 $ 200,000 $ 160,000 Treatments - Owned Centers 768,000 1,792,000 2,560,000 2,560,000 3,712,000 5,184,000 6,784.000 18,240,000 46,144,000 Processing - Licensed Centers 120,000 360,000 775,000 1,357,500 2,612,500 2,000,000 2,755,000 3,585,000 4,385000 12,725,000 24,037,500 Banking 3,520 13,920 42,600 95,880 155.920 168,440 264,220 381,300 508,980 1,322,940 3,432,920 183,520 433,920 1,685,600 3,345.380 5,648.420 4 788 440 6 791 220 9 190 300 11 717,980 32,487,940 73 774,420 Variable Operating Costs Cost of goods sold 20,960 64,560 183,700 354,740 623,960 532,220 758,510 1,023,450 1,295,290 3,609,470 7,869,660 Licensed Facility Fees 36,000 108,000 232,500 407,250 783,750 600,000 826,503 1,075,500 1,315,500 3.817,500 7,211,250 Sales Commission 27,000 51,000 102,500 160,750 341,250 215,000 290,500 368,500 448,500 1.322,500 2,443,750 Owned Center Operating Costs - 490,800 1,145,200 1,636,000 1,636,000 2,165,200 2,726,400 3,300,400 9.828,000 19,242,400 83,960 223,560 1,009,500 2,067.940 3,384.960 2,983 220 4 040 710 5 193 850 6,359,690 18,577,470 36 767,060 Gross Margin 99,560 210,360 676,100 1,277,440 2,263,460 1,805,220 2,750,510 3,996,450 5,358,290 13,910,470 37,007,360 43% 50% Sales, General & Administrative Costs Marketing 125,798 194,239 206,856 223,450 750,347 257,777 307,846 367,723 430,915 1,364,261 2,457,483 Sales and operations 29,738 29,738 65,875 113,313 238,663 123,853 123,853 207,337 207,337 662,380 1,034,190 Research and development 62,250 255,375 257,375 257,375 832,375 330,375 330,375 329,375 329,375 1,319,500 1,617,500 General and administrative 359,050 396,888 495,163 596,888 1,847,988 668,862 707,050 757,425 786.800 2,920,136 3 461 961 576,835. 876,239 1,025,269 1,191,029 3,669,372 1,380,867 1 469 124 1 661 859 1,754,426 6,266 277 8571,134 Net income (loss) from operations (477,275) (665,879) (349,169) 86,411 (1,405,912) 424,353 1,281,386 2,334,591 3,603,864 7,644,193 28,436,226 Other incomeflexpense) 18.5351 116.6371 (27.0571 (36,353 (88.583) 04,as (51.1611 (57.2791 162.9351 215 376 281,349 Income (loss) before income taxes (485,811) (682,516) (376,226) 50,058 11,494,494) 380,351 1,230,225 2.277,312 3,540,929 7,428,817 28,154,877 Provision for income taxes 42.950 842.605 1.310.144 2.195.700 10,417,305 (485,811) (682,516) (376,226) 50,058 11,494,494) 380,351 1,187,275 1,434,707 2,230,785 5.233,118 17,737,573 NON CONTROLLING INTEREST Net income (loss) $ (085,811) $ (682,516) $ (376,226) $ 50,058 $ 11,494,494) $ 380,351 $ 1 187 275 $ 1,434,707 5 2,230,785 $ 5,233,118 $ 17,737,573 EBITDA $ (044,675) $ (601,879) $ (242,119) $ 233,061 $ (1,055,612 $ 606,203 $ 1,501,986 $ 2,588,991 $ 3,891,264 $ 8,588,443 $ 29,850,426 26% 40% inteuicui Finanaal Man US 022011rchtdsz CONFIDENTtAL Quarterly McceneStatement EFTA00619609  IntelKell Biosciences Inc. North America Division Three Year Launch Plan Forecast Quarterly Income Statement Forecast Start Date: 1-Jan-11 Quarter ended Year ended Quarter ends Year ended Year ended 31-Mar-11 30-Jun-11 30-Seu-11 31-Dec-11 31-Dec-11 31-Mar-12 30-Jun-12 30-Seo-12 31-Dec-12 31-Dec-12 31-Dec-13 IntelliCell Financial Pbn US 01-2011reyttlez CONFIDENTIAL Quarterly income Statement EFTA00619610  IntelKell Biosciences Inc. North America Division Three Year Launch Plan Forecast Quarterly Income Statement Forecast Start Date: 1-Jan-11 Quarter ended Year ended Quarter ends Year ended Year ended 31-Mar-11 30-run-ii 30-Sep-II 31-Dec-11 31-Dec-11 31-Mar-12 30-Jun-12 30-Seo-12 31-Dec-12 31-Dec-12 31-Dec-13 OPERATING METRICS Cumulative Licensed Markets Cumulative Owned Markets Operating Metrics intelliCell Financial Pbn US 01-2011revl.the CONFIDENTIAL Quarterly Incase Statement EFTA00619611  IntelWell Biosciences Inc. North America Division Three Year Launch Plan Forecast Quarterly Balance Sheet Forecast Start Date: 1-tan-11 Quarter ended Year ended Quarter ended Year ended I Year ended 31-Mar-11 30-Jun -11 30-Seo-11 31-Dec-11 31-Dec-11 31-Mar-12 30-Jun-12 30-Sep-12 31-Dec-12 31-Dec-12 31-Dec-13 ASSETS CURRENT ASSETS Cash $ 4,051,450 $ 3,221,336 $ 2,535,787 $ 2,328,725 $ 2,328,725 $ 2,406,825 $ 3,266,302 $ 5,212,967 $ 7.633.322 5 7,633,322 $ 26,658,203 Accounts receivable 19,115 41,123 169,218 282,613 282,613 400,395 574,910 754,633 952.401 952,401 1,775,027 Other recievables - - - - - - - Inventory 19,200 48,000 135,200 228,000 228,000 374,400 510,400 648,030 786.400 786,400 1,232,000 Prepaid expenses 18,218 31,690 46,434 41,364 41,364 84,272 93,621 102,799 105,893 105,893 152,515 Total current assets 4,107,982 3,342,149 2,886,639 2,880,703 2,880,703 3,265,892 4,445,233 6,718,399 9,478,017 9,478,017 29,817,746 PROPERTY AND EQUIPMENT Furniture and fixtures 20,000 25,000 35,000 42,500 42,500 45,000 45,000 55,000 55,000 55,000 57,500 Equipment and computers 12,000 15,000 46,000 50,500 50,500 52,000 127,000 133,000 133,000 133,000 134,500 Center furnishings and equipment 620,000 1,240,000 2,060,000 2,840,000 2,840,000 3,540,000 4,240,000 4,900,000 5,560,000 5,560,000 7,540,000 652,000 1,280,000 2,141,000 2,933,000 2,933,000 3,637,000 4,412,000 5,088,000 5,748,000 5,748,000 7,732,000 Accumulated depreciation (32,600) (96,600) (203,650) (350,300) (350,300 (532,150) (752,750) (1,007,150) (1,294.550) (1,294,550) (2,708,750 Property and equipment -net 619,400 1,183,400 1,937,350 2,582,700 2 582 7C0 3,104 850 3,659,250 4,080,850 4,453,450 4,453,450 5,023,250 OTHER ASSETS Other assets $ 4,727,382 $ 4,525,549 5 4,823,989 $ 5,463,403 5 5.463.403 6.370,742 $ 8 104 483 5 10,799,249 5 13,931,467 5 13,931,467 15 34,840,996 LIABIUTIES AND SHAREHOLDER'S EQUITY CURRENT LIABILITIES Current portion - long term debt 83,907 163,473 265,767 356,907 356,907 431,760 501,713 561.353 616.373 616,373 705,553 Accounts payable 14,500 32,500 185,700 309,500 309,500 435,800 580,200 724,700 872,900 872,900 1,432,900 Accrued expenses 24,760 89,608 99,608 109,464 109,464 135,885 145,234 162,938 173,533 173,533 242,547 Income taxes payable - - 42,950 842,605 1,310,144 1,310,144 3,407,186 123,166 285,582 551,075 775 870 775 870 1,003 445 1 270 098 2,291,597 2,972,950 2,972,9501 5,788,186 LONG TERM DEBT 335,627 653,893 1,063,067 1,427,627 1,427,627 1,727,040 2,006,853 2,245,413 2,465,493 2,465,493 I 2,822,213 SHAREHOLDERS EQUITY Common stock 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 Additional paid in capital 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 Retained earnings (485,811) (1,168,326) (1,544,552) (1,494,494) µ,494,494 (1,114,143) 73,132 1,507.838 3,738.623 3 738 623 21,476,196 4,268,589 3,586,074 3,209,848 3,259,906 3,259,906 3,640,257 4,827,532 6.262,238 8,493,023 8,493,023 26,230,596 54.727.382 5 4.525.549 5 4,823,989 S 5,463,403 5 5,463,403 5 6.370.742 5 8.104.483 5 10,799.249 5 13.931.467 5 13,931,467 $ 34,840,996 intananfinarcial Plan US 01.2011 (*gbh.% CONFIDENTIAL Quante.* lance Vet EFTA00619612  IntelMelt Bloscleixes Inc. North America Division Three Year Launch Dian Forecast Quarterly Cash Flow Forecast Start Date: 1-Jan-11 Quarter ended Year ended Quarter ended Year ended Year ended 31-Mar-11 30-hin-11 30-Seo-11 31-Dec-11 31-Dec-11 31-Mar-12 30-lun-12 30-Seo-12 31-Dec-12 II 31-Dec-12 31-Dec-13 Cash flows from operating activities: Net income (loss) (485,811) $ (682,516) $ (376,226) $ 50,058 $ (1,490,494) $ 380,351 $ 1,187,275 $ 1,434,707 $ 2,230,785 5 233 118 $ 17,737,573 Adjustments to reconcile net (loss) to cash provided (used) by operations: Depreciation and amortization 32,600 64,000 107,050 146,650 350,300 181,850 220,600 254,400 287,400 944,250 1,414,200 Amortization of financing costs Change in assets and liabilities: - - Decrease (Increase) in accounts receivable (19,115) (22,008) (128,095) (113,395) (282,613) (117,782) (174,515) (179,723) (197,769 (669,788 (822,626) Decrease (Increase) in inventory (19,200) (28,800) (87,200) (92,800) (228,000) (146,400) (136,000) (137,600) (138,400 (558,400 (445,600) Decrease (increase) in other prepaid expenses (18,218) (13,472) (14,745) 5,070 (41,364) (42,907) (9,349) (9,178) (3,095 (64,529 (46,622) (Decrease) increase in accounts payable 14,500 18,000 153,200 123,800 309,500 126,300 144,400 144,500 148,200 563,400 560,000 (Decrease) increase in accrued expenses 24,760 64,849 10,000 9,856 109,464 26,422 9,349 17,704 10,595 64,069 69,014 (Decrease) increase in income taxes payable - - - - 42,950 799,655 467,538 1,310,144 2,097,042 Net cash provded (used) by operating activities (470,484) (599,947) (336,016) 129,238 (1,277,208) 407,833 1,284,711 2 324 465 2,805,255 6,822,264 20,562,981 Cash flows from investing activities: Initial acquisition of assets Increase in property, plant and equipment (652,000) (628,000) (861,000) (792,000) (2,933,000) (704,000) (775,000) (676,000) (660,000 (2,815,000 (1,984,000) Net cash provded (used) by investing activities (652,000) (628,000) (861,000) (792,000) (2,933,000) (704,000) (775,000) (676,000) 660 000 (2,815,000 (1,984,000) Cash flows from financing activities: Issuance of common stock 4,754,400 - 4,754,400 Increase (decrease) in equipment loans-net 419,533 397 233 511 467 455,700 1 784 533 374,267 349,767 29&200 275,100 1 297 333 445,900 Net cash provded (used) by financing activities 5,173,933 397,833 511,467 455,700 6,538,933 374,267 349,767 298,200 275,100 1,297,333 445,900 Net increase (decrease) in cash 4,051,450 (830,113) (685,550) (207,062) 2,328,725 78,100 859,477 1,946,665 2,420,355 5,304,597 19,024,881 Cash, beginning of period 0 4,051 50 3 221 336 2 535 787 0 2 328 725 2 406 825 3 266 302 5 212 967 2328,725 7 633 322 Cash, end of period lirth - 450 $ 3,221,336 $ 2,535,787 $ 2,328,725 5 2,328,725 $ 2,006,825 $ 3„266 302 $ 5,212,967! $ 7,633,3221 $ 7 633 322 $ 26 658 203 intelliCen financial Pion US D1-2011rrel.tx CONFIDENTIAL Quarterly Cash flow EFTA00619613  IntelilCell Blosciences Inc. North America Division Monthly Income Statement Forecast Start Date: 1-]an-11 TotalYE 31-)an-11 28-Feb-11 31-Mar-11 30-Ant-11 31-May-11 30-Jun-11 31-Jul-11 31-Aue11 30.5ep-11 31-Oct-11 30.Nov.11 31-Dec-11 31-Dec-11 Month 1 Month 2 Month 3 Month 4 Month S Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12 Month 12 Revenues Licensing Revenues -Installations $ 20,000 $ 20,000 $ 20,000 $ 20000 $ 20,000 $ 20000 $ 40,000 $ 40,000 $ 20,000 5 40,000 $ 40,000 $ 20.000 $ 320,000 Equipment Sales -Distributors $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ Treatments -Owned Centers $ - $ - $ - $ - $ - $ - $ 128,000 $ 256,000 $ 384,060 $ 512,000 $ 640,000 $ 640,000 2,560.000 Processing - Licensed Centers $ 20,000 $ 00,000 $ 60,000 $ 90,000 $ 120,000 $ 150000 $ 207,500 $ 265,000 $ 302,500 $ 382,500 $ 462,500 $ 512,500 2,612,500 Processing Kits-Distributors $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - Banking $ 480 $ 1,120 $ 1,920 $ 3,120 $ 4,560 $ 6,240 $ 9,780 $ 14,100 $ 18,720 $ 24,980 $ 32,200 $ 38,700 155,920 40,480 61,120 81,920 113,120 144,560 176,240 385,280 575,100 725,220 959,480 1 174 700 1 211 200 5,648.420 Cost of Sales Cost of goods sold $ 3,440 $ 6,960 $ 10,560 $ 15,960 $ 21,080 $ 27,120 $ 44,490 $ 62,250 $ 76,960 $ 99,290 $ 122,100 $ 133,350 623,960 Licensed Facility Fees $ 6,000 $ 12,000 18.000 $ 27.000 $ 36,000 $ 05,000 $ 62.250 $ 79,500 $ 90,750 114,750 $ 138,750 $ 153,750 783,750 Sales Commission $ 7,00D $ 9,000 $ 11,000 $ 14,000 $ 17,000 $ 20,000 $ 30,750 $ 36,500 $ 35,250 48,250 $ 56,250 $ 56,250 341,250 Owned Center Operating Costs - $ - $ - $ - $ - $ 81,800 $ 163,600 S 245,400 327,200 S 009,000 S 409,000 1,636,000 16 040 27,960 39,560 56,960 74,480 92,120 219,290 341,850 448.360 589.490 726.100 752,350 3 384 960 Gross Margin 24,040 33,160 42,360 56,160 70,080 84,120 165,990 233,250 276,860 369,990 448,600 058,850 2,263.460 Sales, General & Administrative Costs Marketing 36,726 36,932 52,140 59,431 59,746 75,062 62„203 64,101 80,552 67,945 85,097 70,412 750,347 Sales and operations 9,913 9,913 9.913 9,913 9,913 9,913 21,992 21,992 21,892 37,804 37,804 37,704 238,663 Research and development 20,750 20,750 20,750 85,125 85,125 85,125 86,125 86,125 85,125 86,125 86,125 85,125 832,375 General and administrative 119,683 119,683 119,683 130,588 131,150 131,150 163,029 160,092 172,042 201,188 197.875 197,825 1 847 988 187,071 187,278 202,486 289,036 285,933 301,250 333,349 332,309 359,611 393,061 406,901 391,066 3 669 372 Net Income (loss) from operations (163,031) (154,118) (160,126) (232,896) (215,853) (217.130) (167,359) (99,059) (82,751) (23,071) 41,699 67,784 (1,405.912 Other kxometlexpense) (2,893) (2,805) (2,797) (5,642) (5,546) (5,449) (9,179) (9,019) (8,859) (12,339) (12,118) (11,897 (88,583 Income (loss) before Income taxes (165,925) (156,963) (162,923) (238,538) (221,399) (222.579) (176,538) (108,078) (91,609) (35,010) 29,581 55,887 (1,494.494 Provision for Income taxes Income (loss) before non controlling Mines (165,925) (156,963) (162,923) (238,538) (221,399) (222,579) (176,538) (108,078) (91,609) (35,410) 29,581 55.887 (1,494,494 Non controlling interest Net income (loss) $ (165,925) $ (156.963) S (162.923) S (238.538) $ (221,399) $ (222.579) $ (176.538) 5 (108.078) S (91.609) S (35.410) 5 29.581 5 55.887 11,494,494 CONFIDENTIAL Inteilicelinnancialinan05017011reV1.Xla MonthlyineomeStotement EFTA00619614  Intel'Kell Etiosciences Inc. North America Division Monthly Income Statement Forecast Start Date: 1-Jan-11 Total YF 31-Jan-11 28-Feb-11 31-Mat-11 30-Apr-11 31-May-11 30-Jun-11 31-Jul-11 31-Aut-11 30-Sep-11 31-Oct-11 30-Nov-11 31-Dec-11 31-Dec-11 OPERATING METRICS Cumulative Licensed Markets 1 2 3 4 5 6 9 12 14 17 20 21 21 Cumulative Owned Markets 1 1 1 1 1 1 3 3 2 3 3 1 Operating Metrics CONFIDENTIAL intaliCeliFinancial Ran US 012011revl.xla Monthly income Systeme.. EFTA00619615  IntelliCell Bloscientes Int. North America Division Monthly Income Statement Forecast Start Date: Total N't 31-Jan-12 29-Feb-12 31-Mar-12 30-Apr-12 31-May-12 30-Jun-12 31-Jul-12 31-Aua-12 30-Sep-12 31-00-12 30-Nov-12 31-Dec-12 31-Dec-12 Month 13 Month 14 Month 15 Month 16 Month 17 Month 18 Month 19 Month 20 Month 21 Month 22 Month 23 Month 24 Month 24 Revenues Licensing Revenues -Installations $ 20,000 $ 20,000 $ 20,000 $ 20,000 $ 20,000 S 20,000 S 20,000 $ 20,000 $ - $ 20,000 $ 20,000 $ - $ 200,000 Equipment Saes -Distributors $ - $ $ - $ - $ - S - S - $ - $ - $ - $ - $ - $ Treatments - Owned Centers $ 768,000 $ 896000 $ 896000 $ 1,088000 $ 1,280.000 S 1,344,000 $ 1,568,000 $ 1,792,000 $ 1,820,003 $ 2,080,000 $ 2,336,000 $ 2,368,000 18.240400 Processing - Licensed Centers $ 592,500 $ 672,500 $ 735,000 $ 830,000 $ 925,000 S 1,000,000 $ 1,105,000 $ 1,210,000 $ 1,270,000 $ 1,375,000 $ 1,480,000 $ 1,530,003 12.725400 Processing kits-Distributors $ - $ - $ - $ - $ - S - $ - 5 - $ - 5 - $ - 5 - $ Banking $ 47,120 $ 56340 $ 64,980 $ 76,100 $ 88,220 S 99,900 S 113,480 $ 127,680 $ 140,140 $ 154,960 $ 170,300 $ 183,720 1.322,940 1,427,620 1,644,840 1.715,980 2 014 100 2 313 220 2,463,900 2,806,480 3.149,680 3,234,140 3,629,960 0 036 300 4,081,720 32.487.940 Cost of Sales Cost of goods sold $ 156,760 $ 180,570 $ 194,890 $ 225.250 $ 256,110 $ 277,150 $ 311,940 $ 347,040 $ 364,470 $ 401,480 $ 438,750 $ 455,060 3.609,070 Licensed Facility Fees $ 177,750 $ 201,750 $ 220.500 $ 249,000 $ 277.500 S 300,000 $ 331,500 $ 363,000 $ 381,000 $ 412,500 $ 444,000 $ 459,000 5 3,817,500 Sales Commission $ 64,250 $ 72„250 $ 78,500 $ 88,000 $ 97,500 $ 105,000 $ 115,500 $ 126,000 $ 127,000 $ 142,500 $ 153,000 $ 153,000 1,322,503 Owned Center Operating Costs $ 490,800 $ 572,600 $ 572,600 $ 660,800 $ 749,000 $ 755,400 $ 846,800 $ 938„200 $ 941,400 $ 1,036,000 $ 1,130,600 $ 1,133,800 9.828000 889,560 1,027,170 1,066,490 1,223050 1 380 110 1,437,550 1 605 740 1,774„240 1,813,870 1,992,480 2 166 350 2,200,860 18.577,470 Gross Margin 538,060 617,670 649,490 791,050 933,110 1,026,350 1,200,740 1,375,440 1,420,270 1,637,480 1,839,950 1,880,860 13.910470 Sales, General & Administrative Costs Marketing 76,712 82,143 98,921 98,852 117,619 42284 111,184 119,764 136,775 131,771 156,179 142,965 1,364,261 Sales and operation 41,284 41,28A 41584 4 91,2 .384 74 41,28al 69,146 69,146 69,046 69,146 69,146 69,046 662.380 Research and development 110,125 110,125 110,125 110,125 110,125 110,125 110,125 110,125 109,125 110,125 110,125 109,125 1,319,500 General and administrative 223,329 222,767 222,767 235,683 235,683 235,683 254,975 251,350 251,100 262,350 262,350 262,100 2 920 136 451,451 456,319 473,097 478,467 485,945 504,712 545,429 550,380 566046 573,391 597,800 583,235 6.266,277 Net income (loss) from operations 86,609 161551 176,393 312,583 447,165 521,638 655,311 825,056 854,224 1,064,089 1,242,150 1,297,625 7.644,193 Other income/(expense) (14,943) (14,667) (14,392) (17583) (17,054) (16,724) (19,474) (19,093) (18,712) (21,411) (20,978) (20,546 (215,376) Income (loss) before Income taxes 71,667 146684 162,001 295,200 430,111 504510 635,837 805,963 835,512 1,042,678 1,221,172 1,277,079 7,428417 Provisi0n for Income taxes 42,950 235,260 298506 309,140 385,791 451,834 472,519 2.195,700 Income (loss) before non controlling intern 71,667 146684 162,001 295,200 430,111 461,964 400,577 507,757 526,373 656,887 769,338 804560 5.233,118 Non controlling interest Net income (loss) 5 71.667 5 146.684 5 162.001 5 295.200 5 430.111 5 461.964 5 400,577 5 507.757 5 526,373 5 656.887 5 769,338 5 804.560 5 5.233.118 CONFIDENTIAL inuNcenFinancial Ran US 012011revl.xla Monthly income %stow. EFTA00619616  InternCell Bloscientes Int. North America Division Monthly Income Statement Forecast Start Date: Total YE 31-Jan-12 29-Feb-12 31-Mar-12 30-Aor-12 31-May-12 30-Jun-12 31-Jul-12 31-Aug-12 3O-Sep-12 31-Oct-12 30-Nov-12 31-Dec-12 31-Dec-12 OPERATING METRICS Cumulative Licensed Markets 23 25 26 28 30 31 33 35 35 37 39 39 39 Cumulative Owned Markets 2 2 1 2 2 1 2 2 2 2 Operating Metrics CONFIDENT LAI. intaliCeliFinancial RanUs 01.2011revl.xla Monthly income Systeme.. EFTA00619617  IntNIICNI Blosciences Inc. North America Dh4sion Monthly Income Statement Forecast Start Date: Total U 31-Jan-13 28-Feb-13 31-Mar-13 30-Aor-13 31-May-13 30-tun-13 31-lui-13 31-Aut-13 30-54n-13 31-Oct-13 30-Nov-13 31-Dec-13 31-Dec-13 Month 25 Month 26 Month 27 Month 28 Month 29 Month 30 Month 31 Month 32 Month 33 Month 34 Month IS Month 36 Month 36 Revenues Licensing Revenues -Installations $ 20,000 $ 20,000 $ - $ 20,000 $ 20,000 $ - $ 20,000 $ 20,000 $ - $ 20,000 $ 20,000 $ $ 160,000 Equipment Sales -Distributors $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ $ Treatments - Owned Centers $ 2,656,000 $ 2,944,000 $ 2,976,000 $ 3,296,000 $ 3,616,000 $ 3,648,000 $ 3,968,000 $ 4,288,000 $ 4,288,000 $ 4,608,000 $ 4,928,000 $ 4,928,003 $ 46,100,000 Processing - Lkensed Centers $ 1,627,500 $ 1,725,000 $ 1